Skip to main content

Feb 12th Webinar: Denali Transport Vehicle (TV) Technology: DNL310 (ETV:IDS) Ph1/2 Cohort A Interim Data in Hunter Syndrome Patients

Denali Therapeutics
  • Home
  • Scientific Approach
    • Genetic Pathway Potential
    • Engineering Brain Delivery
    • Biomarker-Driven Development
    • Publications
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact
Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2023 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2020 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use